Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Allakos Inc

ALLK
Current price
1.15 USD +0.04 USD (+3.60%)
Last closed 1.1 USD
ISIN US01671P1003
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 94 704 208 USD
Yield for 12 month -61.67 %
1Y
3Y
5Y
10Y
15Y
ALLK
21.11.2021 - 28.11.2021

Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California. Address: 825 Industrial Road, San Carlos, CA, United States, 94070

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.35 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-6 141 000 USD

Last Year

-9 975 000 USD

Current Quarter

Last Quarter

-873 000 USD

Key Figures ALLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -154 723 008 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -48.75 %
PEG Ratio
Return On Equity TTM -121.68 %
Wall Street Target Price 3.35 USD
Revenue TTM
Book Value 0.81 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.03 USD
Diluted Eps TTM -2.03 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALLK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALLK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.5048
Price Book MRQ 1.2651

Financials ALLK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALLK

For 52 weeks

0.54 USD 3.41 USD
50 Day MA 0.94 USD
Shares Short Prior Month 1 711 669
200 Day MA 1.02 USD
Short Ratio 1.24
Shares Short 1 392 927
Short Percent 2.21 %